Patent 7521045 was granted and assigned to Schering on April, 2009 by the United States Patent and Trademark Office.
Methods of inhibiting metastasis or maintenance of various cancers are provided. In particular, the method makes use of fact that certain trafficking of cancers depend upon identified proteins, which serve as markers. Additional methods of screening are also provided.